Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Petra Vočková"'
Autor:
Lucie Lorkova, Michaela Scigelova, Tabiwang Ndipanquang Arrey, Ondrej Vit, Jana Pospisilova, Eliska Doktorova, Magdalena Klanova, Mahmudul Alam, Petra Vockova, Bokang Maswabi, Pavel Klener, Jiri Petrak
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135314 (2015)
Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed M
Externí odkaz:
https://doaj.org/article/934d78619f8049778d49fd8d7f250fbf
Autor:
Pavel Otáhal, Dana Průková, Vlastimil Král, Milan Fabry, Petra Vočková, Lucie Latečková, Marek Trněný, Pavel Klener
Publikováno v:
OncoImmunology, Vol 5, Iss 4 (2016)
Tumor immunotherapy based on the use of chimeric antigen receptor modified T cells (CAR T cells) is a promising approach for the treatment of refractory hematological malignancies. However, a robust response mediated by CAR T cells is observed only i
Externí odkaz:
https://doaj.org/article/36444db72aa843bfa43632d0acc0511d
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
Autor:
Radek Jakša, Jana Karolová, Michael Svatoň, Dmitry Kazantsev, Martina Grajciarová, Eva Pokorná, Zbyněk Tonar, Magdalena Klánová, Lucie Winkowska, Diana Maláriková, Petra Vočková, Kristina Forsterová, Nicol Renešová, Alexandra Dolníková, Kristýna Nožičková, Pavel Dundr, Eva Froňková, Marek Trněný, Pavel Klener
Publikováno v:
Laboratory Investigation. 102:957-965
Non-Hodgkin lymphomas (NHL) represent the most common hematologic malignancies. Patient-derived xenografts (PDXs) are used for various aspects of translational research including preclinical in vivo validation of experimental treatment approaches. Wh
Autor:
Robert, Pola, Eva, Pokorná, Petra, Vočková, Eliška, Böhmová, Michal, Pechar, Jana, Karolová, Jan, Pankrác, Luděk, Šefc, Karel, Helman, Marek, Trněný, Tomáš, Etrych, Pavel, Klener
Publikováno v:
Acta biomaterialia. 119
Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphoma (B-NHL) with chronically relapsing clinical course. Implementation of cytarabine (araC) into induction and salvage regimen became standard of care for majority of MCL patient
Autor:
Peter, Keša, Eva, Pokorná, Martina, Grajciarová, Zbyněk, Tonar, Petra, Vočková, Philippe, Trochet, Milan, Kopeček, Radek, Jakša, Luděk, Šefc, Pavel, Klener
Publikováno v:
Ultrasound in medicinebiology. 47(4)
Tumor oxygenation and vascularization are important parameters that determine the aggressiveness of the tumor and its resistance to cancer therapies. We introduce dual-modality ultrasound and photoacoustic imaging (US-PAI) for the direct, non-invasiv
Autor:
Pavel, Otáhal, Dana, Průková, Vlastimil, Král, Milan, Fabry, Petra, Vočková, Lucie, Latečková, Marek, Trněný, Pavel, Klener
Publikováno v:
Oncoimmunology
Tumor immunotherapy based on the use of chimeric antigen receptor modified T cells (CAR T cells) is a promising approach for the treatment of refractory hematological malignancies. However, a robust response mediated by CAR T cells is observed only i
Autor:
Bokang Calvin Lenyeletse Maswabi, Jan Molinsky, Filipp Savvulidi, Tomas Zikmund, Dana Prukova, Diana Tuskova, Magdalena Klanova, Petra Vockova, Lucie Lateckova, Ludek Sefc, Jan Zivny, Marek Trneny, Pavel Klener
Publikováno v:
Haematologica, Vol 102, Iss 4 (2017)
Externí odkaz:
https://doaj.org/article/4939dddb976741d782de82c5c6d12687